Aion Therapeutic Inc.

AION

CA00905T1021

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 02:57:24 2024-04-24 pm EDT			5-day change	1st Jan Change
0.015 ^CAD	-25.00%		0.00%	-25.00%

Apr. 22	Aion Therapeutic Inc. announced that it expects to receive CAD 0.75 million in funding	CI
Apr. 02	Aion Therapeutic Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	CI

Aion Therapeutic Inc. Reports Earnings Results for the First Quarter Ended July 31, 2021

November 02, 2021 at 09:25 am EDT

Aion Therapeutic Inc. reported earnings results for the first quarter ended July 31, 2021. For the first quarter, the company reported net loss was CAD 0.747081 million compared to CAD 0.517649 million a year ago. Basic loss per share from continuing operations was CAD 0.006 compared to CAD 0.01 a year ago.

Latest news about Aion Therapeutic Inc.

Aion Therapeutic Inc. announced that it expects to receive CAD 0.75 million in funding	Apr. 21	CI
Aion Therapeutic Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	Apr. 01	CI
Aion Therapeutic Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	Jan. 02	CI
Aion Therapeutic Inc. completed the acquisition of Toppen Health Inc.	Dec. 14	CI
Aion Therapeutic Inc. entered into a definitive share purchase agreement to acquire Toppen Health Inc. for $4.9 million.	23-10-22	CI
Aion Therapeutic Inc. entered into a definitive share purchase agreement to acquire Toppen Health for $4.9 million.	23-10-22	CI
Aion Therapeutic Inc. announced that it has received CAD 0.6425 million in funding	23-10-04	CI
Aion Therapeutic Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023	23-09-28	CI
Aion Therapeutic Inc. Reports Earnings Results for the Full Year Ended April 30, 2023	23-08-27	CI
Aion Therapeutic Inc. announced that it has received CAD 0.4275 million in funding	23-08-13	CI
Aion Therapeutic Announces Resignation of Rosy Mondin as Director	23-07-06	CI
Aion Therapeutic Inc. announced that it expects to receive CAD 0.5 million in funding	23-07-03	CI
Aion Therapeutic Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	23-04-03	CI
Aion Therapeutic Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	22-12-30	CI
Aion Therapeutic Inc. Reports Earnings Results for the First Quarter Ended July 31, 2022	22-11-04	CI
Aion Therapeutic Inc. Reports Earnings Results for the Full Year Ended April 30, 2022	22-11-01	CI
Aion Therapeutic Inc. Auditor Raises 'Going Concern' Doubt	22-10-31	CI
Aion Therapeutic Inc. Announces Management and Board Changes	22-06-30	CI
Aion Therapeutic Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2022	22-04-01	CI
Aion Therapeutic Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2021	21-12-30	CI
Aion Therapeutic Inc. Reports Earnings Results for the First Quarter Ended July 31, 2021	21-11-02	CI
Aion Therapeutic Inc. Auditor Raises 'Going Concern' Doubt	21-10-28	CI
Aion Therapeutic Inc. Announces to Open Aion International Center for Psychedelic Psychiatry in Jamaica	21-07-14	CI
Aion Therapeutic Inc. announced that it has received CAD 1.487017 million in funding	21-06-10	CI
Apollon and Aion Formulations Kill Breast Cancer Cells Through Multiple Pathways	21-05-18	CI

Chart Aion Therapeutic Inc.

Duration

Period

More charts

Company Profile

Aion Therapeutic Inc. is a Canada-based company, which operates within the health and wellness sector with a diverse portfolio of intellectual property. The Company, through its subsidiary, AI Pharmaceuticals Jamaica Limited, is engaged in research, development and treatment, as well as new therapeutic formulation discovery using data mining and artificial intelligence (AI) techniques. The Company develops healing chemical compounds from medical cannabis in combination with chemical compounds from psychedelic and edible mushrooms to treat conditions, such as cancer, depression, post-traumatic stress disorder (PTSD) and others, as well as opioid and alcohol addiction. The Company is also engaged in offering a water filtration system that incorporates mechanical filtration, membrane filtration, adsorption, silver infection control, ion exchange, and chemical additions into a three-stage water purification solution designed to meet the needs of consumers, business, and industries.

Sector

Pharmaceuticals

Calendar

2024-08-26 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
AION THERAPEUTIC INC.	-25.00%	6.02M
DONG-E-E-JIAO CO.,LTD.	+38.08%	6.01B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-16.43%	4.47B
TASLY PHARMACEUTICAL GROUP CO., LTD	-12.46%	3.11B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.21%	3.01B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-0.59%	2.6B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+34.54%	1.85B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.93%	1.66B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-10.63%	1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.50%	1.53B